Xiaoying Hu
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling.
Journal: Journal for immunotherapy of cancer
Published: September 01, 2022
Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation.
Journal: Journal for immunotherapy of cancer
Published: July 24, 2020
IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma.
Journal: Journal for immunotherapy of cancer
Published: July 02, 2020
Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors.
Journal: Oncoimmunology
Published: May 13, 2019
Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer.
Journal: Cancer immunology research
Published: October 25, 2018
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
Journal: British journal of cancer
Published: May 26, 2018
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors.
Journal: Frontiers in immunology
Published: March 30, 2018
Interactions among myeloid regulatory cells in cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: February 21, 2018
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.
Journal: Frontiers in immunology
Published: November 30, 2017
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.
Journal: The Journal of clinical investigation
Published: October 12, 2017
Myeloid-derived suppressor cells and tumor escape from immune surveillance.
Journal: Seminars in immunopathology
Published: September 28, 2016
Last Updated: 09/26/2026